Effectiveness of riamilovir in preventing respiratory viral infection among young people from organized collectives

Aim. To evaluate the efficacy of the antiviral drug riamilovir (trade name – «Triazavirin®») for the prevention of SARS-CoV-2 infection (COVID-19) and other acute respiratory viral infections in young people from organized groups. Materials and methods. The study involved 386 individuals aged 18–...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Konstantin V. Kozlov, Oleg V. Maltsev, Kristina V. Kasyanenko, Vitalii S. Sukachev, Andrei V. Saulevich, Sergey S. Karyakin, Alexey D. Dubrovin, Roman N. Smirnov
Formato:	Artigo
Idioma:	Russo
Publicado em:	"Consilium Medicum" Publishing house 2024-12-01
Colecção:	Терапевтический архив
Assuntos:	acute respiratory viral infections acute respiratory diseases riamilovir nucleoside analogues prevention
Acesso em linha:	https://ter-arkhiv.ru/0040-3660/article/viewFile/637437/pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!